Short-Term Safety of Booster Immunization With BNT162b2 mRNA COVID-19 Vaccine in Healthcare Workers

This study demonstrated a favorable short-term safety profile after a third dose of the BNT162b2 vaccine among healthcare workers (HCWs). There were more frequent local reactions and less systemic reactions compared to the second dose. The HCWs who reported reactions had higher prebooster titer of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Paran, Yael, Saiag, Esther, Spitzer, Avishay, Angel, Yoel, Yakubovsky, Michal, Padova, Hagit, Ben-Ami, Ronen, Goldinger, Ilana, Gamzu, Ronni, Sprecher, Eli, Zeltser, David, Henig, Oryan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755369/
https://www.ncbi.nlm.nih.gov/pubmed/35165656
http://dx.doi.org/10.1093/ofid/ofab656
Descripción
Sumario:This study demonstrated a favorable short-term safety profile after a third dose of the BNT162b2 vaccine among healthcare workers (HCWs). There were more frequent local reactions and less systemic reactions compared to the second dose. The HCWs who reported reactions had higher prebooster titer of anti-S1 antibodies compared to those who reported no reactions.

Ejemplares similares